Working… Menu
Trial record 2 of 4 for:    repaglinide | Cystic Fibrosis

Repaglinide for Adolescents With Cystic Fibrosis-Related Diabetes

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00231192
Recruitment Status : Withdrawn (Unable to recruit any subjects)
First Posted : October 4, 2005
Last Update Posted : March 12, 2015
Information provided by:
Children's Hospital of Philadelphia

No Study Results Posted on for this Study
Study was withdrawn before participants were enrolled.
Recruitment Status : Withdrawn
Primary Completion Date : No date given
Actual Study Completion Date : August 2007